Sentinel Lymph Node clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Groningen International Study on Sentinel Nodes in Vulvar Cancer-III
open to eligible females ages 18 years and up
Vulvar cancer patients with SN-metastasis > 2mm will receive chemoradiation instead of an inguinofemoral lymphadenectomy.
at UC Irvine
Our lead scientists for Sentinel Lymph Node research studies include Krishnansu Tewari.
Last updated: